4th Edition of International Heart Congress
June 22-24,2026 | Hybrid Event
Implantable Cardioverter Defibrillator
An Implantable Cardioverter Defibrillator (ICD) is a sophisticated medical device designed to monitor and regulate heart rhythm in individuals at risk of life-threatening arrhythmias. Implanted beneath the skin, typically near the collarbone, the ICD continuously monitors the heart's electrical activity. In the event of a dangerous arrhythmia, the device delivers precisely timed electrical shocks to restore a normal heart rhythm. This crucial intervention can be lifesaving for individuals with conditions such as ventricular tachycardia or ventricular fibrillation. Additionally, modern ICDs often incorporate pacemaker functionality, further assisting in maintaining a steady heart rate. The ICD's capability to provide both defibrillation and pacing makes it a versatile and vital tool in the management of certain cardiac conditions, enhancing the overall quality of life for those at risk of severe arrhythmias.
Shuping Zhong
University of Southern California, United States
Ahdy Wadie Helmy
Indiana University School of Medicine, United States
Federico Benetti
Benetti Foundation, Argentina
Ishan Abdullah
George Washington University School of Medicine and Health Sciences, United States
Sana Tariq
Manchester University NHS Foundation Trust, United Kingdom
Achi Kamaraj
Royal Brisbane and Women’s Hospital, Austria
Agustin Joison
Cordoba Catholic University, ArgentinaSubmit your abstract Today
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Fats of Life, the skinny on statins and beyond !
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Study of pathological cardiac hypertrophy regression
Shuping Zhong, University of Southern California, United States
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Atypical takotsubo cardiomyopathy presenting as st-elevation myocardial infarction
Sana Tariq, Manchester University NHS Foundation Trust, United Kingdom